Bioorganic and Medicinal Chemistry Letters p. 803 - 806 (1996)
Update date:2022-09-26
Topics:
Chapman, Kevin T.
Durette, Philippe L.
Caldwell, Charles G.
Sperow, Kelly M.
Niedzwiecki, Lisa M.
Harrison, Richard K.
Saphos, Cheryl
Christen, Amy J.
Olszewski, Julie M.
Moore, Vernon L.
MacCoss, Malcolm
Hagmann, William K.
Further development of N-carboxyalkyl dipeptide inhibitors of stromelysin-1 (MMP-3) led to the discovery of C-carboxyalkyl dipeptide analogs with improved oral bioavailability. An in vivo assay of human MMP-3 mediated degradation of a macromolecular substrate in an extravascular space is described and inhibition studies are reported.
View MoreFujian Wanke Pharmaceutical Co., LTD.
Contact:+86-598-5026002
Address:Economic development zone,jiangle county
TIANJIN DONGRUXIANG MINERALS MARKETING CO.,LTD(expird)
Contact:22-58516360
Address:tianjin
Zhejiang Hoshine Silicon Industry Co., Ltd.
Contact:86-573-89179966
Address:Zhapu Town, Pinghu City, Zhejiang, China
Contact:+86-531-58668191 58668193 58668196 58661173
Address:No 55,Beixiaoxinzhuang West Street,Jinan City, Shandong Province
Hefei Lifeon Pharmaceutical Co., Ltd.
Contact:+86-551-65328450
Address:No522 Wangjiang West Road
Doi:10.1016/0008-6215(67)85008-0
(1967)Doi:10.1021/om990385y
(2000)Doi:10.1002/ejoc.201402180
(2014)Doi:10.1039/C19660000355
(1966)Doi:10.1016/0040-4039(95)00387-R
(1995)Doi:10.1021/jo00099a037
(1994)
